Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund. (2017)
Attributed to:
DECIPHer: Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/annonc/mdx110
PubMed Identifier: 28453615
Publication URI: http://europepmc.org/abstract/MED/28453615
Type: Journal Article/Review
Volume: 28
Parent Publication: Annals of oncology : official journal of the European Society for Medical Oncology
Issue: 8
ISSN: 0923-7534